文献速递泌尿生殖与妇科肿瘤放疗放疗物理与技术

巴西这一中高收入国家宫颈癌近距离放疗的系统级能力:基于巴西的案例研究

System-Level Capacity of High-Dose Rate (HDR) Brachytherapy for Management of Cervical Cancer in an Upper-Middle Income Country: A Case Study From Brazil.
PubMed 文献 · Int J Radiat Oncol Biol Phys · 2022-06-29

该研究利用巴西政府官方报告数据,评估2001至2021年近距离放疗(BCT)能力变化及2020年宫颈癌放疗可及性。结果显示85%(23/27)的州至少有1台BCT设备,全国每台BCT对应117例需放疗宫颈癌病例,低于每年每台200例的基准;但直线加速器(LINAC)短缺持续存在,各州缺口15至141台,巴西每台BCT对应2.55台LINAC,低于欧洲的3.25台(P=.012)。

要点

  • 巴西85%(23/27)的州至少有1台BCT设备,全国每台BCT对应117例需放疗宫颈癌病例。
  • 每台BCT对应宫颈癌病例数从2013年的142例降至2021年的117例(P<.0001)。
  • 巴西每台BCT对应2.55台LINAC,欧洲为3.25台(P=.012),各州LINAC缺口15至141台。

核心结论

  • 20年间巴西BCT能力已增至可满足宫颈癌需求,但LINAC短缺持续数十年,影响完整治疗的可及性并可能影响肿瘤学结局。
  • 这些数据可帮助组织患者治疗流程、避免治疗延迟并改善生存。

研究设计与样本

  • 利用政府官方报告汇编巴西BCT与LINAC数量、地理分布与覆盖、宫颈癌年发病率与患病率数据。
  • 评估2001至2021年间国家BCT能力变化,以及2020年各州和地区每台BCT对应需放疗宫颈癌病例数、每台BCT对应LINAC数及LINAC供应情况。
  • 使用国际原子能机构数据将巴西每台BCT对应LINAC比例与欧洲比较。

主要发现

  • 85%(23/27)的巴西州至少有1台BCT设备;全国每台BCT对应117例需放疗宫颈癌病例。
  • 以每年每台BCT设备200例宫颈癌病例为基准,巴西全国和地区层面BCT设备数量足以满足容量。
  • 每台BCT对应宫颈癌总病例数从2013年的142例显著降至2021年的117例(P<.0001)。
  • 全国公共系统有252台LINAC,每台LINAC对应1985例新发癌症病例;巴西各地区LINAC短缺范围为15至141台。
  • 巴西每台BCT对应2.55台LINAC,欧洲为3.25台(P=.012)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: Ensuring optimal access to radiation therapy (RT) facilities is challenging for many countries. External beam RT and brachytherapy (BCT) are required to treat advanced cervical cancer. In this analysis, we evaluated the system-level capacity of BCT in Brazil and its relationship with access to complete cervix cancer radiation treatment with both external beam RT and BCT. METHODS AND MATERIALS: We used official government reports to compile data on BCT and linear accelerator (LINAC) numbers, geographic distribution and coverage, cervical cancer annual incidence, and prevalence in Brazil. We also evaluated changes in national BCT capacity between 2001 and 2021. The 2020 relationship between cervical cancer cases for RT per BCT unit, LINAC per BCT unit, and the LINAC supply for each Brazilian state and region were evaluated. For comparison, the LINAC per BCT unit ratio in Brazil was compared with Europe using International Atomic Energy Agency data. RESULTS: Eighty-five percent (23/27) of Brazilian states have at least 1 BCT unit; nationally, there are 117 cervical cancer cases for RT per BCT unit. Compared with the benchmark of 200 cervical cancer cases per BCT device per year, there are enough BCT units to fill capacity in Brazil nationally and regionally. The ratio of total cervix cancer cases per BCT unit decreased substantially over time from 142 in 2013 to 117 in 2021 (P < .0001). Nationally, there are 252 LINAC units in the public system with a ratio of 1985 new cancer cases/LINAC. Brazilian regions have a LINAC shortage ranging from 15 to 141 units. There were 2.55 LINACs per BCT unit in Brazil, compared with 3.25 in Europe (P = .012). CONCLUSIONS: Over 20 years, BCT capacity in Brazil has increased to meet the cervical cancer demand. However, the LINAC shortage has persisted over the decades, affecting access to complete treatment and possibly the oncological outcomes. These data can help organize the patient treatment flow, avoid treatment delays, and improve survival.

来源:Int J Radiat Oncol Biol Phys,查看原文。版权归原作者所有。

引用

  1. Gouveia AG, Viani GA, Bratti VF, et al. System-Level Capacity of High-Dose Rate (HDR) Brachytherapy for Management of Cervical Cancer in an Upper-Middle Income Country: A Case Study From Brazil. Int J Radiat Oncol Biol Phys. 2022. PMID: 35779808. doi:10.1016/j.ijrobp.2022.06.074

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。